(Q57365063)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16752169%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Plasma apolipoprotein A5 and triglycerides in type 2 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16752169%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16752169%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

G M Dallinga-Thie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16752169%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

A van Tol

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16752169%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

H Hattori

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16752169%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

L C van Vark-van der Zee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16752169%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

H Jansen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16752169%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

DALI study group

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16752169%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

28 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16752169%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16752169%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16752169%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16752169%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

1505-1511

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16752169%20AND%20SRC:MED&resulttype=core&format=json

Cardiovascular disease mortality in familial forms of hypertriglyceridemia: A 20-year prospective study

29 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-006-0261-0

Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-006-0261-0

Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-006-0261-0

Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators

21 January 2018

1 reference

12 December 2020

Postprandial increase of plasma apoAV concentrations in Type 2 diabetic patients

1 reference

12 December 2020

The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia

1 reference

12 December 2020

3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase

1 reference

12 December 2020

Association of apolipoprotein A5 variants with LDL particle size and triglyceride in Japanese Americans

1 reference

12 December 2020

Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5

1 reference

12 December 2020

Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

1 reference

12 December 2020

Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren

1 reference

12 December 2020

The apoAI-CIII-AIV gene cluster

1 reference

12 December 2020

A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration

1 reference

12 December 2020

SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population

1 reference

12 December 2020

Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase.

1 reference

12 December 2020

The single nucleotide polymorphism -1131T>C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia

1 reference

12 December 2020

Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia

1 reference

12 December 2020

The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins

1 reference

12 December 2020

Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia

1 reference

12 December 2020

HDL: Structure, function and metabolism

1 reference

12 December 2020

Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.

1 reference

12 December 2020

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

12 December 2020

Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides

1 reference

12 December 2020

Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III.

1 reference

12 December 2020

Determination of the functionality of common APOA5 polymorphisms

1 reference

12 December 2020

Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides

1 reference

12 December 2020

Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants

1 reference

12 December 2020

Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiation

1 reference

12 December 2020

Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels

1 reference

12 December 2020

An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing

1 reference

12 December 2020

Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids

1 reference

12 December 2020

Analysis of apolipoprotein A5, c3, and plasma triglyceride concentrations in genetically engineered mice

1 reference

12 December 2020

Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice

1 reference

12 December 2020

ApoA-V: the regulation of a regulator of plasma triglycerides

1 reference

12 December 2020

Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice

1 reference

12 December 2020

10.1007/S00125-006-0261-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16752169%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference